Non-Operative Management of Musculoskeletal Diseases and Regenerative Medicine.
10.4055/jkoa.2018.53.5.375
- Author:
Joo Han OH
1
;
Sung Min RHEE
Author Information
1. Department of Orthopaedic Surgery, Seoul National University College of Medicine, Seoul National University Bundang Hospital, Seongnam, Korea. starsmstar@daum.net
- Publication Type:Review
- Keywords:
regenerative medicine;
stem cell;
prolotherapy;
platelet-rich plasma;
extracorporeal shockwave therapy
- MeSH:
Animals;
Cartilage;
Hand;
Musculoskeletal Diseases*;
Orthopedic Procedures;
Orthopedics;
Platelet-Rich Plasma;
Regeneration;
Regenerative Medicine*;
Stem Cells;
Surgeons;
Tendons
- From:The Journal of the Korean Orthopaedic Association
2018;53(5):375-380
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Recently, due to the unsatisfactory outcomes of several orthopedic surgical procedures, non-operative management of musculoskeletal diseases, including regenerative medicine, is becoming more attractive to orthopedic surgeons. Regarding the healing of musculoskeletal tissues, such as bone, cartilage and tendons, regenerative medicine aims to replace or promote tissue regeneration. Among them, therapy using stem cells, prolotherapy, platelet-rich plasma, and extracorporeal shockwave therapy are taking center stage. Numerous animal and clinical studies have been published and the number has increased exponentially in recent years. On the other hand, because regenerative medicine in the orthopedic field is still in the early stages, no definite methods for the procedures have been made and there is some controversy regarding their application to musculoskeletal disease. Therefore, more high quality studies including randomized studies should be performed to establish standards and evaluate their value in the orthopedic field.
